Cancer patients face an elevated risk of bleeding, and here platelets play a pivotal role. The
association between platelet count and bleeding, as well as safe thresholds for prophylactic …

Lung cancer is the most common cancer and the leading cause of cancer death in the world,
among which non-small cell lung cancer (NSCLC) accounts for about 85% of the total lung …

Purpose To describe expected imaging features on chest computed tomography (CT) after
percutaneous radiofrequency ablation (RFA) of lung tumors, and their frequency over time …

Background Centrally located lung tumors present treatment challenges given their
proximity to mediastinal structures including the central airway, esophagus, major vessels …

Purpose To assess the potential risk factors for pneumothorax secondary to pulmonary
radiofrequency (RF) ablation. Materials and Methods Six electronic databases were …

Percutaneous ablation of small non–small cell lung cancer (NSCLC) has been
demonstrated to be both feasible and safe in nonsurgical candidates. Radiofrequency …

Although surgical resection is the primary means of curing both primary and metastatic lung
cancers, about 80% of lung cancers cannot be removed by surgery. As most patients with …

AIM To determine local control, safety, and survival following percutaneous computed
tomography (CT)-guided high-power microwave ablation (MWA) in the treatment of primary …

Purpose The purpose of this study was to retrospectively determine the incidence of early
enlarging cavitation after percutaneous radiofrequency ablation (RFA) of lung tumor and …

Purpose Radiofrequency ablation (RFA) is a curative treatment option for small lung
metastases, which conventionally involves multiple freehand manipulations until the treating …